Detalhe da pesquisa
1.
CAR T Cells Targeting MISIIR for the Treatment of Ovarian Cancer and Other Gynecologic Malignancies.
Mol Ther
; 28(2): 548-560, 2020 02 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31870622
2.
Quantitative Control of Gene-Engineered T-Cell Activity through the Covalent Attachment of Targeting Ligands to a Universal Immune Receptor.
J Am Chem Soc
; 142(14): 6554-6568, 2020 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32191035
3.
T-cell target antigens across major gynecologic cancers.
Gynecol Oncol
; 145(3): 426-435, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28377094
4.
TCRvß-CART therapy mediates high-precision targeting of malignant T-cell clones.
Blood Adv
; 7(9): 1885-1898, 2023 05 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36053778
5.
Rapid, site-specific labeling of "off-the-shelf" and native serum autoantibodies with T cell-redirecting domains.
Sci Adv
; 8(18): eabn4613, 2022 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35522741
6.
Expression of inducible factors reprograms CAR-T cells for enhanced function and safety.
Cancer Cell
; 40(12): 1470-1487.e7, 2022 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36513049
7.
Macrophage-Based Approaches for Cancer Immunotherapy.
Cancer Res
; 81(5): 1201-1208, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33203697
8.
CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapy.
Nat Commun
; 12(1): 877, 2021 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33563975
9.
The Emergence of Universal Immune Receptor T Cell Therapy for Cancer.
Front Oncol
; 9: 176, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30984613